NDAINTRAMUSCULAR, SUBCUTANEOUSINJECTABLE
Approved
May 2003
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
4/8 — Partial
ADRENACLICK (epinephrine) by Fresenius Kabi is adrenergic alpha-agonists [moa]. Approved for anaphylaxis, cardiac arrest, ventricular fibrillation. First approved in 2003.
Drug data last refreshed 20h ago
Mechanism of Action
Adrenergic alpha-Agonists
Pharmacologic Class:
alpha-Adrenergic Agonist
Indications (3)
Worked on ADRENACLICK at Fresenius Kabi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.